R. Bergen

发表

Safety of cold-adapted live attenuated influenza vaccine in a large cohort of children and adolescents

E. Lewis, R. Walker, S. Black, 2004, The Pediatric infectious disease journal.

Comparison of primary sensitization of naive human T cells to varicella-zoster virus peptides by dendritic cells in vitro with responses elicited in vivo by varicella vaccination.

E. Engleman, D. Jenkins, A. Arvin, 1999, Journal of immunology.

Vaccination Responses Elicited In Vivo by Varicella Peptides by Dendritic Cells In Vitro with Human T Cells to Varicella-Zoster Virus Comparison of Primary Sensitization of Naive

E. Engleman, D. Jenkins, A. Arvin, 1998 .

Rate of Congenital Toxoplasmosis in Large Integrated Health Care Setting, California, USA, 1998–2012

M. Manos, Jeffrey L. Jones, R. Bergen, 2014, Emerging infectious diseases.

Safety and immunogenicity of Chiron/Biocine recombinant acellular pertussis-diphtheria-tetanus vaccine in infants and toddlers.

E. Lewis, S. Black, D. Granoff, 1997, The Pediatric Infectious Disease Journal.

Human T cells recognize multiple epitopes of an immediate early/tegument protein (IE62) and glycoprotein I of varicella zoster virus.

A. Arvin, M. Sharp, R. Bergen, 1991, Viral immunology.

The T-lymphocyte response to varicella-zoster viral proteins.

A. Arvin, P. Diaz, C. Koropchak, 1990, Advances in experimental medicine and biology.

The immunogenicity of the Oka/Merck varicella vaccine in relation to infectious varicella-zoster virus and relative viral antigen content.

A. Arvin, P. Diaz, R. Bergen, 1990, The Journal of infectious diseases.

Age-related differences in cell-mediated immunity to varicella-zoster virus among children and adults immunized with live attenuated varicella vaccine.

A. Arvin, M. Sharp, R. Bergen, 1995, The Journal of infectious diseases.

Neonatal Sepsis Workups in Infants ≥2000 Grams at Birth: A Population-Based Study

Bruce F. Folck, G. Escobar, M. N. Gardner, 2000, Pediatrics.